Claudio Ucciferri

1.6k total citations
74 papers, 1.1k citations indexed

About

Claudio Ucciferri is a scholar working on Epidemiology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Claudio Ucciferri has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 25 papers in Infectious Diseases and 24 papers in Emergency Medicine. Recurrent topics in Claudio Ucciferri's work include HIV-related health complications and treatments (22 papers), COVID-19 Clinical Research Studies (11 papers) and HIV/AIDS drug development and treatment (8 papers). Claudio Ucciferri is often cited by papers focused on HIV-related health complications and treatments (22 papers), COVID-19 Clinical Research Studies (11 papers) and HIV/AIDS drug development and treatment (8 papers). Claudio Ucciferri collaborates with scholars based in Italy, United States and Myanmar. Claudio Ucciferri's co-authors include Jacopo Vecchiet, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Marta Di Nicola, Pio Conti, Margherita D’Alessandro, Francesco Cipollone, Claudia Petrarca and Antonio Abbate and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Claudio Ucciferri

67 papers receiving 1.1k citations

Peers

Countries citing papers authored by Claudio Ucciferri

Since Specialization

Citations

This map shows the geographic impact of Claudio Ucciferri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Ucciferri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Ucciferri more than expected).

Fields of papers citing papers by Claudio Ucciferri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Ucciferri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Ucciferri. The network helps show where Claudio Ucciferri may publish in the future.

Co-authorship network of co-authors of Claudio Ucciferri

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Ucciferri. A scholar is included among the top collaborators of Claudio Ucciferri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Ucciferri. Claudio Ucciferri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	URO-RESIST: A Real-World Retrospective Study on Multidrug-Resistant Sepsis with Urinary Tract Infection, Clinical Predictors, Inflammatory Biomarkers, and Patient Outcomes 2025 ·Antibiotics ·(unknown), Claudio Tana, Claudio Ucciferri, (unknown), (unknown), Katia Falasca	0
2	Gut Microbiota, Mild Cognitive Impairment and Dementia: A Systematic Review 2025 ·Neurology International ·Claudio Tana, (unknown), Marco Tana, Claudio Ucciferri, (unknown)	0
3	Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen 2024 ·BMC Infectious Diseases ·(unknown), Claudio Ucciferri, (unknown), Paola Borrelli, Marta Di Nicola, (unknown), Erica Costantini, (unknown), Marcella Reale, Jacopo Vecchiet	2
4	Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis 2023 ·Therapeutics and Clinical Risk Management ·Felice Nava, Alessandra Mangia, (unknown), Lorenzo Somaini, Francesco Giuseppe Foschi, Ernesto Claar, Ivana Maida, Claudio Ucciferri, Francesca Frigerio, (unknown), (unknown), Valentina Perrone, Luca Degli Esposti, Massimo Puoti	1
5	Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 2023 ·Diagnostics ·Giulia Renda, Marco Mennuni, (unknown), (unknown), (unknown), Simona De Vecchi, Anna Degiovanni, (unknown), Enrico Guido Spinoni, Leonardo Grisafi, (unknown), Claudio Ucciferri, Katia Falasca, Jacopo Vecchiet, Sabina Gallina, Giuseppe Patti	0
6	Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected? 2023 ·Immunity Inflammation and Disease ·Claudio Ucciferri, (unknown), (unknown), Jacopo Vecchiet, Katia Falasca	3
7	Early detection of pleuro‐pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature 2022 ·SHILAP Revista de lepidopterología ·Giulio Cocco, Andrea Boccatonda, Ilaria Rossi, Damiano D’Ardes, Antonio Corvino, Andrea Delli Pizzi, Claudio Ucciferri, Katia Falasca, Jacopo Vecchiet	7
8	New Therapeutic Options in Mild Moderate COVID-19 Outpatients 2022 ·Microorganisms ·Claudio Ucciferri, (unknown), Paola Borrelli, Marta Di Nicola, Jacopo Vecchiet, Katia Falasca	6
9	Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 2022 ·International Journal of Molecular Sciences ·Beatrice Dufrusine, (unknown), (unknown), (unknown), Paola Lanuti, Damiana Pieragostino, Piero Del Boccio, (unknown), (unknown), (unknown), Nerino Allocati, Katia Falasca, Claudio Ucciferri, (unknown), (unknown), (unknown), Jacopo Vecchiet, Vincenzo De Laurenzi, Enrico Dainese	10
10	Molnupiravir as an Early Treatment for COVID-19: A Real Life Study 2022 ·Pathogens ·(unknown), Claudio Ucciferri, Paola Borrelli, Marta Di Nicola, Jacopo Vecchiet, Katia Falasca	9
11	It is Not Always COVID-19: Case Report about an Undiagnosed HIV Man with Dyspnea 2021 ·Current HIV Research ·(unknown), Katia Falasca, Jacopo Vecchiet, Claudio Ucciferri	2
12	Parameters associated with diagnosis of COVID‐19 in emergency department 2021 ·Immunity Inflammation and Disease ·Claudio Ucciferri, (unknown), Marta Di Nicola, Paola Borrelli, (unknown), (unknown), Jacopo Vecchiet, Katia Falasca	11
13	Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 2021 ·Nutrients ·Marcella Reale, Claudio Ucciferri, Erica Costantini, Marta Di Nicola, Annamaria Porreca, Pamela Di Giovanni, (unknown), (unknown), Jacopo Vecchiet, Katia Falasca	1
14	Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 2020 ·Microorganisms ·Damiano D’Ardes, (unknown), Lucia Esposito, (unknown), Andrea Boccatonda, Ilaria Rossi, Marco Bucci, Maria Teresa Guagnano, Claudio Ucciferri, Francesca Santilli, Marta Di Nicola, Katia Falasca, Jacopo Vecchiet, (unknown), Francesco Cipollone	17
15	Disfunzione vascolare nei pazienti con infezione da HIV. 2017 ·(unknown), Claudio Ucciferri, (unknown), Jacopo Vecchiet	0
16	Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 2016 ·AIDS Research and Human Retroviruses ·Katia Falasca, Marcella Reale, Claudio Ucciferri, Marta Di Nicola, Giuseppe Di Martino, Chiara D’Angelo, Simona Coladonato, Jacopo Vecchiet	21
17	Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 2012 ·PubMed ·Claudio Ucciferri, Katia Falasca, Paola Mancino, Angelo Di Iorio, Jacopo Vecchiet	20
18	Proteinuria in an African HIV-infected patient: effects of telmisartan. 2011 ·PubMed ·Claudio Ucciferri, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Jacopo Vecchiet	1
19	Acute urinary retention due to HSV-1: a case report. 2009 ·PubMed ·Paola Mancino, Miriana d’Alessandro, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet	4
20	Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response 2009 ·Journal of Medical Virology ·Katia Falasca, Claudio Ucciferri, Paola Mancino, (unknown), Eligio Pizzigallo, Jacopo Vecchiet	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact